Intero Biosystems
PrivateLast Round
Pre Seed
Jun 11, 2025
Total Funding Raised
$2.96M
Company Overview
Intero Biosystems is a biotechnology company that develops advanced human intestinal organoids for preclinical drug testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Intero Biosystems Comparables
Compare Intero Biosystems with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neiges Biotechnologies | 84% | |
| Greenstone Biosciences | 80% | |
| VivoSim Labs, Inc. | 76% |
Intero Biosystems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Jun 11, 2025 | ||||
| Grant | Apr 15, 2025 | ||||
| Grant | Oct 10, 2024 | ||||
| Grant | Sep 1, 2024 | ||||
| Grant | Apr 26, 2024 |
Key People
Founding team and executive leadership
Intero Biosystems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GOOSE Capital | Pre Seed, Grant |
| nCourage Investment Group | Pre Seed |
| Santa Clara Ventures | Pre Seed |
| Michigan Rise | Pre Seed |
| Evoce Capital | Pre Seed |
| Kalamazoo Forward Ventures | Pre Seed |
| Accelerate Blue Fund | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 11, 2025
$2M raised from multiple venture capital firms.
- Apr 15, 2025
Attended the 2025 Rice Business Plan Competition on April 15, 2025.
Recent news
Latest coverage and updates
- recognized_asOct 16, 2026
Biotech startup Intero Biosystems takes top honors at TechCrunch Disrupt’s 2026 Startup Battlefield on Oct 16th '26.
- receives_financingOct 16, 2026
Intero Biosystems receives the $100K grand prize at TechCrunch Disrupt 2026 after competing against 200 startups.
- attends_eventOct 15, 2026
Intero Biosystems beats 199 other Startup Battlefield companies to win the $100,000 grand prize at TechCrunch Disrupt 2026 on Oct 15th '26.
- is_developingOct 14, 2026
Intero Biosystems is developing human intestinal organoids, lab-grown tissue that mimics the gut, to study how drugs and other compounds affect the human body before human testing in Colorado on Oct 15th '26.
Intero Biosystems Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Intero Biosystems's valuation, stock price, and market status.
Is Intero Biosystems a public or private company?
Intero Biosystems is a private company.
What is the current stock price of Intero Biosystems?
Intero Biosystems is a private company, so its shares have no public market price. Caplight tracks Intero Biosystems's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Intero Biosystems worth (valuation)?
Valuation information for Intero Biosystems is not publicly available.
Can I buy Intero Biosystems stock?
Intero Biosystems shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Intero Biosystems's last funding round?
Intero Biosystems's most recent funding round was Pre Seed on June 11, 2025.
Who are the main investors in Intero Biosystems?
Key investors in Intero Biosystems include GOOSE Capital.
Will Intero Biosystems IPO soon?
No public IPO plans have been announced for Intero Biosystems.
How can I track Intero Biosystems secondary market activity?
Caplight tracks bids, offers, and trades in Intero Biosystems's shares on secondary markets.